Selecting the Best Prostate Cancer Surgeons and Hospitals in India: A Guide for Patients from Iraq

Author:- Dr. Dheeraj Bojwani Date Created:- 24-07-2026

Over the years, I have found that prostate cancer surgery is one of the areas where Iraqi men most often present later than ideal, and a genuinely important Indian-specific study helps explain why this matters and what it does not change. In my experience of 24 years advising patients through exactly this decision, the honest picture is this: Indian and South Asian men frequently present with more advanced disease at the time of diagnosis, largely reflecting less routine PSA screening, but once treated by an experienced surgical team, their cancer-control outcomes have been shown to be genuinely comparable to Western patients, which is a reassuring and important distinction to understand clearly.

Healing Journeys of Iraqi Patients

Iraqi Patients Share Their Experience

Why the Choice of Urologic Surgeon in India Matters as Much as the Choice of Technique

Based on my interactions with international patients, a study directly comparing Asian-Indian and Caucasian patients undergoing robotic radical prostatectomy by the same surgeon found that Indian men had significantly more aggressive pathological features at the time of surgery, yet achieved comparable biochemical recurrence-free survival afterward, a finding the study’s authors specifically highlighted as reassuring given the more advanced disease Indian patients typically presented with. The choice between robotic and open surgical technique also carries genuinely different outcomes: a large comparative study found five-year biochemical recurrence-free survival of 81 percent with robotic-assisted surgery compared with 67 percent for traditional open surgery, a difference driven largely by a substantially lower positive surgical margin rate with the robotic approach, 14.0 percent compared with 42.9 percent. Long-term data from a twenty-year multi-country registry following robotic prostatectomy patients found prostate-cancer-specific survival of 97.6 percent and overall survival of 85.5 percent at fifteen years, though patients with cancer that had already spread to lymph nodes at the time of surgery saw meaningfully lower survival, 72.5 percent cancer-specific and 52.1 percent overall at the same fifteen-year mark. This tells a family something important: your specific disease stage at diagnosis, and whether robotic technique is genuinely available and well-practiced at your chosen centre, both meaningfully shape your realistic outcome.

How Patients from Iraq Can Verify a Prostate Cancer Hospital’s Accreditation in India

The fastest filter I recommend to every Iraqi man calling about prostate cancer surgery is verifiable accreditation, not marketing language. Joint Commission International, JCI, audits a hospital’s overall clinical safety systems against the same standard used across the United States and Europe. The National Accreditation Board for Hospitals and Healthcare Providers, NABH, is India’s own domestic equivalent, and in my experience of 24 years advising patients on this exact decision, a centre holding both marks together is a meaningfully stronger signal than either alone. For prostate cancer surgery specifically, ask one further, very direct question: what is this surgeon’s own positive surgical margin rate, since published research has repeatedly identified this specific figure as one of the clearest predictors of long-term cancer control.

Prostate Surgery Volume and Stage-Specific Criteria That Predict Outcomes in India

Based on my interactions with dozens of urologic oncology programmes over the years, a surgeon’s specific volume and their own margin and recurrence rates, not a single general prostate cancer success statistic, are among the clearest predictors of a good outcome. A surgeon’s overall career volume still provides useful context, but published research has specifically identified positive surgical margin rate, a figure that varies meaningfully even among experienced surgeons, as one of the strongest predictors of whether cancer returns. Ask directly, in writing:

1. What is my specific disease stage and risk category, and what does this surgeon's own data show for biochemical recurrence-free survival at this specific stage?
2. What is this surgeon's own positive surgical margin rate, and how many robotic radical prostatectomies have they personally performed?
3. If my disease is locally advanced or has spread to nearby lymph nodes, how does this specifically change the surgical plan and the realistic outcome I should expect?
4. What is the surgeon's approach to nerve-sparing technique, and how does this decision balance cancer control against preserving continence and sexual function for my specific case?

A surgeon confident in their own outcomes will answer these specifically. A surgeon who quotes only a general success percentage without engaging with your specific stage and risk category deserves a second opinion before you commit.

Vetting a Prostate Cancer Hospital in India: A Guide for Patients from Iraq

Questions Patients from Iraq Should Ask About the Prostate Cancer Team in India

Prostate cancer surgery is never genuinely the work of one surgeon alone. In my experience of 24 years watching these programmes operate, the strongest units bring together a urologic oncologist with specific high-volume robotic prostatectomy experience, a medical oncologist for cases needing hormone therapy or chemotherapy, a radiation oncologist for cases where radiotherapy may be an alternative or additional treatment, and a pathologist experienced specifically in prostate cancer grading, since accurate grading directly determines the treatment plan. A dedicated continence and pelvic floor physiotherapist is a further valuable role, since structured post-operative rehabilitation has been shown to meaningfully speed the return of urinary continence after surgery. Ask specifically who fills each of these roles for your case, and confirm that your case has been discussed by a genuine multidisciplinary team before a final treatment recommendation is made.

Prostate Surgery Technology Standards in India That Patients from Iraq Should Check

The specific technology available changes what precision a surgical team can achieve. Ask whether robotic-assisted surgery is genuinely available and how many procedures the specific surgical team, not simply the hospital in general, has performed using this technology. Ask whether multiparametric MRI is used before surgery to precisely map the tumour and plan the nerve-sparing approach, since this level of pre-operative detail has been associated with more accurate surgical planning. Ask also whether the hospital offers intraoperative frozen section analysis, a technique allowing the surgical team to check margin status during the operation itself and extend the resection immediately if needed, rather than discovering a positive margin only after surgery is complete. Ask directly which of these specific capabilities apply to your case, not simply whether the hospital owns robotic surgical equipment somewhere in the building.

Red Flags Patients from Iraq Should Watch For When Choosing a Prostate Cancer Hospital in India

Over the years, certain patterns have become reliable warning signs for me. A surgeon who cannot state their own positive surgical margin rate has not given you the single figure most consistently linked to long-term cancer control. A hospital that quotes a single general success percentage without asking about your specific disease stage and risk category has not engaged with the factors that most determine your realistic outcome. A hospital that does not discuss nerve-sparing technique and its trade-offs specifically for your case has not given you the complete picture needed to weigh cancer control against quality of life afterward. And a hospital that does not offer a genuine multidisciplinary review for locally advanced or lymph-node-positive disease is treating a more complex case with the same approach used for straightforward, early-stage cancer.

Factors Every Patient from Iraq Should Weigh Before Choosing Prostate Cancer Surgery in India

A Closing Thought for Iraqi Men

Prostate cancer surgery deserves a surgeon with genuine, high-volume experience and transparent margin and recurrence data specific to your disease stage, not a single reassuring percentage borrowed from a different risk category. Based on my interactions with international patients over more than two decades, the patients who ask about stage-specific outcomes, surgical margin rates, and genuine robotic experience consistently achieve better-informed, more predictable results than those who accept a general reassurance alone. My role, and the role of any advisor a patient works with, should be to help you ask these exact questions and confirm honestly that the specific surgeon and specific hospital in front of you are the right fit for your exact diagnosis. Iraq’s patients deserve the same standard of scrutiny in this decision as any patient anywhere else in the world.

Sources & Further Reading

• Joint Commission International (JCI) — Accredited Organizations Directory (jointcommissioninternational.org)
• National Accreditation Board for Hospitals & Healthcare Providers (NABH), India (nabh.co)
• Indian Journal of Urology — Pathological Outcomes and Strategies for Optimal Cancer Control in Robotic Radical Prostatectomy in Asian-Indian Men (doi.org)
• PMC — Robotic Assisted Radical Prostatectomy Improves Biochemical Recurrence-Free Survival: The PROCA-Life Study (ncbi.nlm.nih.gov/pmc)
• ScienceDirect — Prostate Cancer-Specific and All-Cause Mortality After Robot-Assisted Radical Prostatectomy: 20 Years' Report, EAU Robotic Urology Section (sciencedirect.com)

Frequently Asked Questions by Iraqi Patients about Selecting a Prostate Cancer Surgeon and Hospital in India